Jefferies analyst Michael Yee assigned a Buy rating to Viridian Therapeutics (VRDN – Research Report) today and set a price target of ...

Building upon a successful end-of-Phase 2 meeting, received FDA "Study May Proceed" letter for pivotal Phase 3 trial of amezalpat (TPST-1120) combination therapy to treat first-line HCCAnnounced agree ...

Tenthoff covers the Healthcare sector, focusing on stocks such as Sutro Biopharma, Moderna, and Arrowhead Pharmaceuticals. According to TipRanks, Tenthoff has an average return of -12.6% and a 32.18% ...